https://www.thebodypro.com/article/fda-approves-first-pi-based-single-tablet-treatmen
Cobicistat/Darunavir/Emtricitabine/Tenofovir Alafenamide (Symtuza, D/C/F/TAF)News

FDA Approves First PI-Based Single-Tablet Treatment for HIV -- How Will It Be Used?

    Paul E. Sax, M.D.

    Paul E. Sax, M.D.

    Dr. Sax is director of the HIV Program and Division of Infectious Diseases at Brigham and Women's Hospital (BWH) in Boston.

    NEJM Journal Watch

    NEJM Journal Watch

    NEJM Journal Watch helps clinicians save time and stay informed by providing them with brief, clearly written, clinically focused perspectives on the medical developments that affect practice.